Manchester’s newest entertainment destination, located over at the ever-growing Etihad Campus, has finally been given a name ahead of its launch later this year.
Alongside the recently announced and Radisson-run hotel, Medlock Square will see the Manchester City-partnered mini leisure district aim to become a new must-visit part of the city.
Hoping to draw in crowds beyond just matchdays and those heading to concerts across the way, approximately £300 million is being pumped into the project.
With Co-op Live having already brought huge revenues into Greater Manchester, it isn’t just set to be a pricey development, but one that will look to serve as yet another money spinner for the wider City Football Group (CFG) and the City Region.
Credit: CFG (supplied)
Unveiling the first CGIs of the square this week, this new area will essentially see attractions and activities spill out of the Etihad Stadium, Co-op Live and the soon-to-open Medlock hotel and on to the campus as a whole.
ADVERTISEMENT
With other parts of Sportcity already revolving around the footballing epicentre, such as the Manchester Regional Arena and National Squash Centre, this will not only see even more sporting events and supporters brought to the roughly 80-acre plot, but also fans of various other forms of entertainment.
For instance, within the plans that already include the food and drink offerings you would expect – with Radisson Blu backing more of the relaxation and indulgent side of things – other activities include everything from “an adrenaline-fuelled sky walk experience”, as well as zip-wire and abseiling.
ADVERTISEMENT
We already knew about some of these from the details in Man City’s stadium expansion plans (including the likes of The Medlock and rooftop bar), and glimpses of the impending hotel opening gave us a better idea of the overall look, but there looks to be plenty more in the pipeline.
You can see a trailer for what they have in mind for Medlock Square down below.
Welcome to Medlock Square. Manchester’s newest entertainment destination. A place where mouthwatering cuisine and world class entertainment, experiences and events converge. Coming soon! pic.twitter.com/4bC7NQbMHT
As per an official press release by the fledgling team, more information on further business and employment opportunities has also now been confirmed, centring around the new ‘One Medlock Square’ structure that will be built on the campus.
ADVERTISEMENT
“Designed to accommodate up to 300 employees, the state-of-the-art workspace will offer high-quality, modern office facilities alongside access to shared event spaces and wellness amenities, uniquely positioned within Manchester’s most exciting new destination”, the statement reads.
There’s certainly some ambitious stuff in the works, put it that way.
And, of course, these will also slot into a renovated club shop turned meagstore, an all-new Man City museum, the Co-op arena, live music and other open-air events, just to name a few. A specific opening date is yet to be scheduled, but you can guarantee it’ll be a big deal when it does launch.
Featured Images — Publicity pictures (supplied via City Football Group)
News
Yet another major Deansgate Locks nightlife spot has closed in Manchester
Daisy Jackson
Deansgate Locks is set to lose yet another of its nightlife spots, with Ark confirming it will be shutting its doors ‘within weeks’.
The multi-room, multi-storey, multi-genre nightclub has been part of the canalside development for more than a decade, having first opened back in 2014.
At that time, Deansgate Locks was arguably Manchester’s leading nightlife destination, drawing hundreds of students and party-goers to its mix of venues.
The railway arches have been home to iconic clubs and bars including Baa Bar, Lola Lo, Revolution, and Sugar Buddha, as well as The Comedy Store.
But with news that Ark Manchester is closing too, it leaves only Popworld left at what was previously one of the city’s hottest destinations.
In a statement shared with the Manchester Evening News, a spokesperson for Stonegate said: “The hospitality sector continues to face significant challenges.
Ark Manchester will be closing for goodIt leaves Deansgate Locks with just one venue
“After careful consideration, and despite our best efforts, Ark Manchester is no longer commercially viable and we have taken the difficult decision to close the venue.
“Our priority is to support our hard‑working team during this time, and we would like to thank them for their commitment and dedication. We would also like to thank our guests and the local community for their support over the years.”
It’s believed that Ark Manchester will close on Deansgate Locks in the next few weeks.
Groundbreaking endometriosis tests could help catch diagnosis ‘years earlier’
Danny Jones
In some major public health news, two pioneering and crucially faster tests for endometriosis, which are set to be rolled out across Great Britain soon, could be about to reduce the time taken to diagnose the condition by several years.
That’s according to the National Institute for Healthand Care Excellence (NICE), who have issued an update revealing that the fresh testing technology could significantly speed up the process that can currently take the best part of a decade or even more.
In some cases, it can take upwards of 11 years to fully identify endometriosis, especially within certain ethnically diverse communities, but now the executive non-departmental public body has given the green light for the NHS to introduce the pair of expeditious testing methods here in the UK.
Announced on Tuesday, 7 July, the dual approach – one half of which is already being used domestically as part of a pilot study – won’t serve as a standalone diagnostic system in itself, but should help drastically reduce the time between suspected symptoms, confirmation and treatment.
In the UK, average diagnosis takes over 9 years.
Endosure and Endotest can now be used in the NHS while more evidence is gathered.
Emma Cox, chief executive of Endometriosis UK, said in a public statement: “Availability of these new tests needs to go hand-in-hand with education of GPs and practice nurses to ensure prompt access to those that need them, and an end to pain and symptoms not being recognised.”
The two prongs of this new approach revolve around the already in-trialEndotest®, currently being manufactured by French biotech company Ziwig.
Essentially a straightforward saliva test, it’s been recommended for wider use over some time now.
Meanwhile, the second step is ‘EndoSure’: a non-invasive test that uses “topical electrode pads similar to those used in an electrocardiogram (ECG) to measure the myoelectric activity of the smooth muscle of the GI tract”, with sensors placed on the stomach area.
You can see an instructional video explaining more information about the former down below.
Put in the simplest terms, in tandem, they could save one in 10 women lots of time and pain.
Dr Anastasia Chalkidou, healthtech programme director at NICE, went on to add: “A diagnosis of endometriosis can for some women take the best part of a decade […] That delay means living with chronic pelvic pain that affects daily life, relationships and work.
“These technologies have the potential to change that by giving primary care professionals better non-invasive tools to identify endometriosis earlier, allowing earlier and better treatment.
“Our draft guidance reflects our commitment to getting promising innovations to patients quickly, while making sure the evidence to support their wider use is built in a rigorous way.”
While both are still pending full approval and eventual scaling across the country, here’s hoping it can make the difference in the lives of millions of British women and beyond.
Danny Jones -
5th March 2026 
